Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

PARGY-LAD

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
PARGY-LAD
Clinical data
Other namesPARGYLAD; PROPARGYL-LAD; PROPARGYLLAD; 6-Propynyl-6-nor-LSD;N,N-Diethyl-6-propargyl-6-norlysergamide;N,N-Diethyl-6-(prop-2-yn-1-yl)-9,10-didehydroergoline-8β-carboxamide
Routes of
administration
Oral[1]
Drug classSerotonin receptor modulator;Serotonergic psychedelic;Hallucinogen
Legal status
Legal status
Identifiers
  • (6aR,9R)-N,N-diethyl-7-prop-2-ynyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
CAS Number
PubChemCID
ChemSpider
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC22H25N3O
Molar mass347.462 g·mol−1
3D model (JSmol)
  • CCN(CC)C(=O)[C@@H]2C=C1c3cccc4[nH]cc(C[C@H]1N(C2)CC#C)c34
  • InChI=1S/C22H25N3O/c1-4-10-25-14-16(22(26)24(5-2)6-3)11-18-17-8-7-9-19-21(17)15(13-23-19)12-20(18)25/h1,7-9,11,13,16,20,23H,5-6,10,12,14H2,2-3H3/t16-,20-/m1/s1 checkY
  • Key:BPJKJUFQSNRQCR-OXQOHEQNSA-N checkY
  (verify)

PARGY-LAD, also known as6-propynyl-6-nor-LSD or6-propargyl-6-nor-LSD, is apsychedelic drug of thelysergamide family related tolysergic acid diethylamide (LSD).[3]

Use and effects

[edit]

PARGY-LAD ishallucinogenic similarly to LSD, but is considerably lesspotent than LSD, with a dose of 160 μg producing only mild effects, and 500 μg required for full activity.[1]

Interactions

[edit]
See also:Psychedelic drug § Interactions, andTrip killer § Serotonergic psychedelic antidotes

Chemistry

[edit]

Analogues

[edit]

Analogues of PARGY-LAD includeLSD,ETH-LAD,PRO-LAD,AL-LAD,BU-LAD, andMAL-LAD, among others.

History

[edit]

PARGY-LAD was developed byDavid E. Nichols and colleagues atPurdue University in the 1980s[3] and is described byAlexander Shulgin in his 1997 bookTiHKAL (Tryptamines I Have Known and Loved).[1]

See also

[edit]

References

[edit]
  1. ^abc"#51. PRO-LAD".Shulgin A,Shulgin A (September 1997).TiHKAL: The Continuation.Berkeley, California:Transform Press.ISBN 0-9630096-9-9.OCLC 38503252.
  2. ^"Arrêté du 20 mai 2021 modifiant l'arrêté du 22 février 1990 fixant la liste des substances classées comme stupéfiants".www.legifrance.gouv.fr (in French). 20 May 2021.
  3. ^abNichols DE, Oberlender R, McKenna DJ (1991)."Stereochemical Aspects of Hallucinogenesis". In Watson RR (ed.).Biochemistry and Physiology of Substance Abuse. Vol. 3. Boca Raton, Fla.: CRC Press. pp. 1–39.ISBN 978-0-8493-4463-3.OCLC 26748320.TABLE 1 Effects of N-(6)-Alkyl Subtituents on LSD-Like Behavior and Serotonin Receptor Affinity in Rats [...]

External links

[edit]
Tryptamines
No ring subs.
4-Hydroxytryptamines
5-Hydroxytryptamines
5-Methoxytryptamines
Other ring subs.
α-Alkyltryptamines
Others
Cyclized
Bioisosteres
Phenethylamines
Scalines
2C-x
3C-x
DOx
4C-x
Ψ-PEA
MDxx
FLY
25x-NB (NBOMes)
Others
Cyclized
Lysergamides
  • Bioisosteres:JRT
Others
Natural sources
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Ergolines
(incl.lysergines)
Clavines
(6,8-dimethylergolines)
Lysergamides
(lysergic acid amides)
Ergopeptines
(peptide ergolines)
Partial ergolines
Related compounds
Natural sources
Retrieved from "https://en.wikipedia.org/w/index.php?title=PARGY-LAD&oldid=1320163853"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp